At OXB, our people are at the heart of everything we do. We’re on a mission to enable life‑changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

We are currently recruiting for a Group Financial Reporting Manager to join the Finance team. The Group Financial Reporting Manager plays a central role within finance, with responsibility for Global department reporting, technical accounting matters, Group taxation, Foreign exchange hedging and treasury.

Our Finance team provides financial reporting, control, and accountancy across the business.

Your responsibilities in this role would be:

• Primary responsibility for advising on technical issues, preparing the IFRS Accounting Papers and maintaining external reporting compliance
• Managing the Group Month End Close process including the Group Consolidation entries and Intercompany; reporting on Group departments and has responsibility for Group’s Balance Sheet and Cash flow.
• Group taxation including transfer pricing, Group Treasury lead including foreign exchange hedging and a key contributor in Internal Control Compliance.
• Responsible for maintaining relationships with stakeholders across the Global business to support the compliant consolidation of the externally reported numbers

We are looking for:

• Qualified Accountant.
• Proven experience as a qualified accountant working within finance or an accounting practice.
• Strong technical experience with IFRS 15.
• Good understanding of financial reporting and processes in a business environment
• Good knowledge and experience of ERP systems processes and transactions
• Good Microsoft Office skills with advanced skills in MS Excel.
• Strong communicator with the ability to build relationships cross‑functionally.
• Ability to adapt to change in an agile way.

About us:

OXB is a quality and innovation‑led viral vector CDMO with a mission to enable its clients to deliver life‑changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno‑associated virus (AAV) and adenoviral vectors. OXB’s world‑class capabilities span from early‑stage development to commercialisation. These capabilities are supported by robust quality‑assurance systems, analytical methods, and depth of regulatory expertise.

• Wellbeing programs that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State‑of‑the‑art labs and manufacturing facilities
• A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future‑focused and growing fast. We succeed together—through passion, commitment, and teamwork.